Scott Greenfeder Selected Research

Scott Greenfeder Research Topics

3	Asthma (Bronchial Asthma) 08/2002 - 03/2002
2	Respiratory Hypersensitivity 06/2012 - 03/2002
2	Flushing 01/2012 - 02/2011
2	Dyslipidemias (Dyslipidemia) 01/2012 - 02/2011
2	Inflammation (Inflammations) 03/2011 - 08/2002
1	Fatty Liver 03/2011
1	Non-alcoholic Fatty Liver Disease 03/2011
1	Body Weight (Weight, Body) 03/2011
1	Hyperinsulinism (Hyperinsulinemia) 03/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2009
1	Pain (Aches) 11/2004
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2002
1	Cough 08/2002
1	Hyperventilation 08/2002
1	Bronchial Spasm 08/2002

2	TachykininsIBA 06/2012 - 08/2002
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2012 - 02/2011
1	Alanine Transaminase (SGPT)IBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	EnzymesIBA 03/2011
1	pyrimidineIBA 02/2011
1	oxidized low density lipoproteinIBA 01/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009
1	capsazepineIBA 11/2004
1	CationsIBA 11/2004
1	SCH 206272IBA 08/2002
1	Capsaicin (Zostrix)FDA Link 08/2002
1	Substance PIBA 08/2002
1	Neurokinin AIBA 08/2002
1	Interleukin-5 (Interleukin 5)IBA 03/2002
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 03/2002

1	Therapeutics 08/2002